PERSPECTIVE THERAPEUTICS ANNOUNCES CLINICAL COLLABORATION AND SUPPLY AGREEMENT WITH MERCK TO EVALUATE [212PB]PSV359 IN COMBINATION WITH KEYTRUDA® (PEMBROLIZUMAB) IN FAP-Α POSITIVE SOLID TUMORS

Reuters · 3d ago

Please log in to view news